Reply to: Rong Dai and Changkai Deng’s Letter to the Editor re: Anirban Dey, Georgios Georgiadis, Justin Umezurike, et al. Mirabegron Versus Placebo and Other Therapeutic Modalities in the Treatment of Patients with Overactive Bladder Syndrome—A Systematic Review. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2024.09.012

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 917af8032d16174b-LAX IP: 47.97.18.252 UTC time: 2025-02-25T22:00:32+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4

Comments (0)

No login
gif